Interstitial Lung Disease Trial, Recruiting NCT06756230 Sponsor: Saglik Bilimleri Universitesi Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT06756230
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a lung condition called IPF (Idiopathic Pulmonary Fibrosis), based on recognised international medical guidelines.
  • People who are between 18 and 75 years old.
  • People who are able to walk on a treadmill.
  • People who are able to follow instructions and cooperate with the study team.
  • People whose current medications have not changed in the past month.
  • People who have not taken part in any structured exercise or activity program for at least six months.
  • People who voluntarily agree to take part and sign a consent form after being informed about the study's purpose and methods.

Who may not be able to join:

  • People who have a physical or mental condition that would prevent them from giving informed consent or following the study's requirements.
  • People who are likely to miss more than 20% of the lung rehabilitation sessions.
  • People who have a serious heart or cardiovascular condition, such as coronary artery disease, uncontrolled high blood pressure, irregular heartbeat, or heart failure.
  • People who have existing bone, joint, or muscle conditions that limit their ability to exercise.
  • People who are currently experiencing a sudden worsening of their IPF symptoms (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02164189616

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Saglik Bilimleri Universitesi
Registry
ClinicalTrials.gov
Start date
13 May 2025
Est. completion
28 February 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

6 Minutes Walking Distance (6MWD); Saint George Quality of life questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov